Main Line pharma company reports 'exciting step forward' with experimental autism treatment
May 27, 2020 at 11:02 AM EDT
Zynerba released the positive results of a phase-II study testing its lead new drug candidate Zygel.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.